Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your prescriber has started you on 2.5 mg Mounjaro and you've been dispensed a 5mg KwikPen, you're not alone in feeling confused. Each 5mg KwikPen contains four weekly doses of 1.25 mg — not 2.5 mg — and the pen is pre-set by the manufacturer. You cannot draw a 2.5 mg dose from it by any manual adjustment. The 2.5 mg starting dose is delivered by the dedicated 2.5 mg KwikPen, which contains four weekly doses of 2.5 mg each. These are separate, distinct products. Mounjaro is a prescription-only medicine; how and when you progress through doses is a clinical decision, made by your prescriber in line with the NHS patient guidance on tirzepatide and your individual response to treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is easy to see where this idea comes from. Mounjaro's licensed schedule begins at 2.5 mg, and the next step is 5mg, so it is tempting to assume the 5mg pen could yield two starter doses. It cannot. Every Mounjaro KwikPen is an auto-injector built around a single fixed-dose cartridge. When you press the button, the device delivers its pre-set amount in full, there is no dial, no graduated window, and no mechanism for stopping partway. The 5mg pen releases 5mg of tirzepatide per use, across four injections. The 2.5 mg pen releases 2.5 mg per injection, also across four uses. Both pens look broadly similar, which adds to the confusion.
Trying to stop the injection mid-way, or pressing only briefly, does not give you a halved dose. You will either receive the full dose or an unknown, inaccurate one. Neither outcome is what your prescriber intended. If you are unsure which pen you have been dispensed, the label and the outer carton both state the strength clearly. You can also read more about the full Mounjaro treatment overview to understand how the KwikPen range is structured.
The bottom line: if your prescription is for 2.5 mg, you need the 2.5 mg KwikPen. Full stop.
Mounjaro's titration schedule is designed with tolerance in mind. The opening dose exists to let your digestive system adjust to a GIP and GLP-1 receptor agonist, two gut-hormone pathways being activated at once. Starting low reduces the likelihood of early nausea, vomiting and discomfort that can discourage people from continuing. The 2.5 mg pen is sometimes described colloquially as a starter, and that framing is accurate: your prescriber is building your tolerance before moving to a dose that carries more weight-management effect.
This also means it is not a sign that treatment is failing if nothing dramatic happens in the first four weeks. The 2.5 mg injection technique page covers preparation and administration in detail, but the clinical rationale is simple: slow and steady titration protects you. Your prescriber will review your response before any increase, assessing both tolerability and weight trend. Dose timing, titration steps and the decision to progress are all set out in your Patient Information Leaflet and confirmed by your prescribing team, they are not decisions to make unilaterally.
If you are approaching your first injection and want reassurance on the steps involved, the guide to injecting from the 5mg pen explains the shared technique across the Mounjaro pen family, which applies once you have been titrated up.
Occasionally people receive a 5mg pen when their prescription is for 2.5 mg, or vice versa. This can happen during supply transitions, or when a patient is mid-titration and there has been a dispensing query. Do not inject until you are certain your pen matches your current prescription. The carton and the pen label both state the strength; compare them to your prescription or the covering letter from your pharmacy.
The MHRA's published guidance on GLP-1 medicines reinforces that these are prescription-only treatments requiring clinical oversight, they should be sourced from a pharmacy you can verify on the GPhC register, not from unregulated sellers where the product, dose and even basic safety cannot be confirmed. If there is any mismatch or doubt, the right step is to contact your prescriber or dispensing pharmacy directly. At nume, patients can reach our clinical aftercare team seven days a week through our contact page. A quick message is always better than guessing.
For context on how Mounjaro's costs and supply work in the UK private market, our guide to sourcing Mounjaro online safely covers what to look for in a legitimate pharmacy and what the verified UK price landscape looks like. It is a useful read before committing to any provider.
Once you have confirmed you have the correct strength pen for your prescribed dose, injection technique is straightforward. Clean the injection site (abdomen, thigh or upper arm) with an alcohol swab and let it dry. Remove the pen cap, check that the liquid is clear and colourless, and press the pen firmly against the skin until you feel or hear the click that signals delivery has begun. Hold the pen in place for the full duration indicated in your Patient Information Leaflet, releasing early can result in an incomplete dose. Rotate your injection site each week to avoid tissue reactions at any single spot.
Storage matters too: Mounjaro pens should be kept refrigerated between 2°C and 8°C. There is a limited window during which the pen may be kept at room temperature, but the exact duration is set out in your Patient Information Leaflet and the Mounjaro SmPC on the eMC, not here, follow those, not a general estimate from any online source. If you are preparing for your second dose from the same pen, our page on injecting the second dose of Mounjaro walks through what to check before reuse. Further general questions about the treatment are covered in our FAQs.
If anything about your dose, your pen or your titration schedule feels unclear, speaking to a prescriber is always the right move. You can start a free consultation with the nume clinical team and have your questions reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.